1-11 of 11
Philip Imus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Personalized Desensitization for DSAs in Allogeneic Blood or Marrow Transplantation: Impact on Graft Outcomes and Access to Transplant

Free
Christian Gocke, Marianna Zahurak, Ilias Sinanidis, Suraya Berger, Javier Bolanos-Meade, Ephraim Fuchs, Alex Ambinder, Philip Imus, Amy DeZern, Rick Jones, Ravi Varadhan, Maria Bettinotti
Journal: Blood
Blood (2025) 146 (Supplement 1): 510.
https://doi.org/10.1182/blood-2025-510
Published: 2025
Journal Articles

CAR-seet 01: A pilot study for diagnosing CRS and icans using wearable consumer devices

Free
Nazila Shafagati, corey baker, Nina Wagner-Johnston, B. Douglas Smith, Syed Abbas Ali, mariana salvatori, Ravi Varadhan, Philip Imus, Cole Sterling
Journal: Blood
Blood (2025) 146 (Supplement 1): 2641.
https://doi.org/10.1182/blood-2025-2641
Published: 2025
Journal Articles

Acute Lymphoblastic Leukemia (ALL) Outcomes after Allogeneic Blood or Marrow Transplantation (alloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) in the Era of More Effective Pre-Transplant Therapy

Free
Jonathan Allen Webster, Madison C Reed, Hua-Ling Tsai, Philip Imus, B. Douglas Smith, Alexander J. Ambinder, Mark J. Levis, Amy E. DeZern, Gabrielle T. Prince, Javier Bolanos-Meade, Lukasz P. Gondek, Gabriel Ghiaur, William Brian Dalton, Theodoros Karantanos, Suman Paul, Ephraim Joseph Fuchs, Cole Sterling, Lode J. Swinnen, Nina Wagner-Johnston, Richard F. Ambinder, Christian B. Gocke, Syed Abbas Ali, Carol Ann Huff, Leo Luznik, Ravi Varadhan, Richard J. Jones, Ivana Gojo
Journal: Blood
Blood (2024) 144 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2024-212141
Published: 2024
Journal Articles

Use of Baseline Inflammatory Markers to Predict Toxicities Among Relapsed/Refractory Multiple Myeloma Patients Receiving Ambulatory Teclistamab and Talquetamab

Free
Nadeem Tabbara, Michael Singel, Natalie Allen, Audra Shedeck, Kathy Mooney, Kathryn Campion, Callan Raymond, Inna Sabirzhanova, Karen Anderson, Sarah Waheed, Carol Ann Huff, Syed Abbas Ali, Christian B. Gocke, Philip Imus
Journal: Blood
Blood (2024) 144 (Supplement 1): 7232.
https://doi.org/10.1182/blood-2024-210189
Published: 2024
Journal Articles

Non-Engrafting CD8-Depleted Human Leukocyte Antigen (HLA) Mismatched Unrelated Donor Lymphocyte Infusion (DLI) Achieves Remissions in Transplant-Naive Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (sAML)

Free
Hany Elmariah, Jongphil Kim, Kayla Reid, Christopher Cubitt, Andrew T. Kuykendall, Jeffrey E Lancet, Rami S. Komrokji, David Sallman, Eric Padron, Onyee Chan, Kendra L. Sweet, Alison R. Walker, Albert J Ribickas, Stephanie Dormesy, Debra A Kessler, Priscilla M Abedu, Asmita Mishra, Farhad Khimani, Lia Perez, Joseph A. Pidala, Claudio Anasetti, Ephraim Joseph Fuchs, Philip Imus, Michael D. Jain, Frederick L. Locke, Marco Davila, Nelli Bejanyan, Amy E. DeZern
Journal: Blood
Blood (2024) 144 (Supplement 1): 2071.
https://doi.org/10.1182/blood-2024-208021
Published: 2024
Journal Articles

The Composite Health Risk Assessment Model (CHARM) Predicts Risks of Toxicities, Functional and Cognitive Decline Among Survivors of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): A Prospective BMT-CTN Study 1704

Free
Mohamed Sorror, Wael Saber, Brent R. Logan, Nancy Geller, Anna Bellach, Jianqun Kou, William A. Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Asmita Mishra, Joseph Uberti, Parastoo B Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence E Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca Olin, Joseph E. Maakaron, Ronald Sobecks, Sarah A. Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew Artz
Journal: Blood
Blood (2024) 144 (Supplement 1): 685.
https://doi.org/10.1182/blood-2024-194414
Published: 2024
Journal Articles

The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1704

Free
Andrew Artz, Brent R. Logan, Wael Saber, Nancy Geller, Anna Bellach, Jianqun Kou, William Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Tammy Schuler, Asmita Mishra, Joseph Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R McCurdy, Lawrence Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Mohamed Sorror
Journal: Blood
Blood (2023) 142 (Supplement 1): 109.
https://doi.org/10.1182/blood-2023-173855
Published: 2023
Journal Articles

A Phase IB/II Study of Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia (ALL) and B-Cell Non-Hodgkin Lymphoma (NHL) As Post-Allogeneic Blood or Marrow Transplant (alloBMT) Remission Maintenance

Free
Jonathan Allen Webster, Richard J. Jones, Amanda Blackford, Audra Shedeck, Richard F. Ambinder, Lode J. Swinnen, Nina Wagner-Johnston, Ephraim Joseph Fuchs, Javier Bolanos-Meade, Philip Imus, Challice L. Bonifant, Heather Jill Symons, Tania Jain, Gabrielle T. Prince, Mark J. Levis, Leo Luznik, Ivana Gojo
Journal: Blood
Blood (2023) 142 (Supplement 1): 3582.
https://doi.org/10.1182/blood-2023-191047
Published: 2023
Journal Articles

A Phase I Trial of Activated Donor-Derived Marrow Infiltrating Lymphocytes to Treat Relapsed Hematologic Malignancies after Allogeneic Transplantation with Post-Transplantation Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis

Free
Joseph Rimando, Francesco Mazziotta, Alison Gareau, Maria Bettinotti, Jonathan Allen Webster, Syed Abbas Ali, Philip Imus, Mario Victor Lemas, Amy E. DeZern, Mark J. Levis, Marianna Zahurak, Ravi Varadhan, Richard F. Ambinder, Carol Huff, Ivana Gojo, Richard J. Jones, Ivan M. Borrello, Leo Luznik
Journal: Blood
Blood (2023) 142 (Supplement 1): 3473.
https://doi.org/10.1182/blood-2023-179394
Published: 2023
Journal Articles

Immunoglobulin Heavy Chain Variable Region (IgHV) Unmutated, but Not Mutated, Chronic Lymphocytic Leukemia (CLL) Arises in a CD34+ Progenitor

Free
Brandy Perkins, Margaret M. Showel, MD, Laura Schoch, MS, NP, Philip Imus, MD, Gabriel Ghiaur, MD PhD, Douglas E. Gladstone, MD, Richard J. Jones, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1709.
https://doi.org/10.1182/blood.V130.Suppl_1.1709.1709
Published: 2017
Journal Articles

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Free
Jordan M. Schecter, MD, Daniela Hoehn, MD, PhD, Philip Imus, MD, Eleonora Alma, BS, Suzanne Lentzsch, MD, PhD, Bachir Alobeid, MD, Manuela Orjuela, MD, ScM, Owen A. O'Connor, MD, PhD, Govind Bhagat, MD
Journal: Blood
Blood (2013) 122 (21): 4333.
https://doi.org/10.1182/blood.V122.21.4333.4333
Published: 2013